In one paragraphArticle in Human molecular genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Jaakko SarparantaFolkhälsan Research Center, Helsinki, Finland and Medicum, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290 Helsinki, Finland.ORCID 0000-0002-5497-5255 Per Harald JonsonFolkhälsan Research Center, Helsinki, Finland and Medicum, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290 Helsinki, Finland.ORCID 0000-0003-2423-359X Anna ViholaFolkhälsan Research Center, Helsinki, Finland and Medicum, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290 Helsinki, Finland.ORCID 0000-0001-9249-8480 Helena LuqueFolkhälsan Research Center, Helsinki, Finland and Medicum, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290 Helsinki, Finland.
Rocío-Nur Villar-QuilesCentre de Référence des Maladies Neuromusculaires, Institut de Myologie, Centre de Recherche en Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, F-75651 Paris Cedex 13, France.ORCID 0000-0001-6706-3506 Tanya StojkovicCentre de Référence des Maladies Neuromusculaires, Institut de Myologie, Centre de Recherche en Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, F-75651 Paris Cedex 13, France.ORCID 0000-0002-4054-2838 Veronica SianFolkhälsan Research Center, Helsinki, Finland and Medicum, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290 Helsinki, Finland.ORCID 0000-0002-8670-744X Charlotte WalderFolkhälsan Research Center, Helsinki, Finland and Medicum, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290 Helsinki, Finland.
Tiina SuominenNeuromuscular Research Center, Tampere University Hospital and Fimlab Laboratories, Teiskontie 35, FI-33520 Tampere, Finland.
Peter HackmanFolkhälsan Research Center, Helsinki, Finland and Medicum, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290 Helsinki, Finland.ORCID 0000-0001-7890-5713 Norma B RomeroCentre de Recherche en Myologie, GH Pitié-Salpêtrière, Sorbonne Université-Inserm UMRS974, 47-83 boulevard de l'Hôpital, F-75651 Paris Cedex 13, France.ORCID 0000-0001-7714-0069 Bruno EymardCentre de Référence des Maladies Neuromusculaires, Institut de Myologie, Centre de Recherche en Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, F-75651 Paris Cedex 13, France.ORCID 0000-0002-9142-1382 Bjarne UddFolkhälsan Research Center, Helsinki, Finland and Medicum, University of Helsinki, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290 Helsinki, Finland.ORCID 0000-0002-1101-9730 Funding
AIMFinska LäkaresällskapetFolkhälsan Research FoundationJane and Aatos Erkko FoundationSigrid Jusélius Foundation
6 · The paper itselfAbstract
The small heat shock protein HSPB6 (a.k.a. Hsp20) is highly expressed in striated and smooth muscles. It modulates the oligomerization of its paralogs HSPB1 and CRYAB (HSPB5) and is involved e.g. in cytoskeletal regulation and autophagy. While HSPB6 variants have been implicated in cardiomyopathy, they have not been previously linked to neuromuscular disease. We report here a patient with late-onset myopathy and cataract, carrying in cis the novel HSPB6 variant c.464delC and the common polymorphism c.488G > C, together resulting in the extended protein p.Pro155Argfs*25;p.Gly163Arg. The family history was consistent with dominant inheritance. The mutant protein showed decreased solubility due to phase separation propensity, and caused mislocalization of CRYAB and BAG3, and a decrease of HSPB1 in transfected cells. The patient's muscle biopsy showed rimmed vacuoles and, in line with the functional studies, accumulation of HSPB6 and its interaction partners. The identified HSPB6 variants are most likely the cause of the muscle disease in this family, thus identifying HSPB6 mutations as a novel cause of vacuolar myopathy. Other reported HSPB6 variants causing a late frameshift or extension may cause disease in a similar fashion.
Indexed as
CataractHSP20 Heat-Shock ProteinsMuscular DiseasesAdaptor Proteins, Signal Transducingalpha-Crystallin B ChainApoptosis Regulatory ProteinsFemaleHeat-Shock ProteinsHumansMaleMiddle AgedMolecular ChaperonesMuscle, SkeletalMutationPedigreeAdaptor Proteins, Signal Transducingalpha-Crystallin B ChainApoptosis Regulatory ProteinsBAG3 protein, humanCRYAB protein, humanHeat-Shock ProteinsHSP20 Heat-Shock ProteinsHSPB1 protein, humanHSPB6 protein, humanMolecular Chaperonescataractchaperoneheat shock proteinmyopathyphase separation
Identifiers
PMID41294008
PMCPMC13158247
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390